Concepedia

Sussie Hopkins

SH

Statistics

Publications

3

Citations

80

H-Index

3

Active since

1992

Affiliations

AstraZeneca (United States)(Current)

Sussie Hopkins is an author at AstraZeneca (United States) specializing in novel antibacterial drug discovery, antibacterial pharmacology, and topoisomerase ii inhibitors.

Publications per year

1992–2014

3

Publications

3

NBTI 5463 Is a Novel Bacterial Type II Topoisomerase Inhibitor with Activity against Gram-Negative Bacteria and <i>In Vivo</i> Efficacy

Thomas J. Dougherty, Asha S. Nayar, Joseph Newman et al. · Antimicrobial Agents and Chemotherapy · 2014 · 45 citations · Full text

, , +15

Optimization of physicochemical properties and safety profile of novel bacterial topoisomerase type II inhibitors (NBTIs) with activity against Pseudomonas aeruginosa

Folkert Reck, David E. Ehmann, Thomas J. Dougherty et al. · Bioorganic & Medicinal Chemistry · 2014 · 25 citations · Full text

, , +15

Fluticasone propionate

Sussie Hopkins · Drugs of today · 1992 · 10 citations

1–3 of 3